Cargando…

Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects

Objective: In obese men, the increased expression of the aromatase enzyme in adipose tissue leads to high conversion of androgens to estrogens contributing to hypogonadotropic hypogonadism (HHG). Our objective is to evaluate efficacy and safety of weight loss (WL) plus aromatase inhibitor (AI) thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colleluori, Georgia, Chen, Rui, Turin, Christie G., Vigevano, Francesca, Qualls, Clifford, Johnson, Biju, Mediwala, Sanjay, Villareal, Dennis T., Armamento-Villareal, Reina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243137/ https://www.ncbi.nlm.nih.gov/pubmed/32499757 http://dx.doi.org/10.3389/fendo.2020.00277

Ejemplares similares

MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial
por: Colleluori, Georgia, et al.
Publicado: (2019)

Testosterone therapy and bone quality in men with diabetes and hypogonadism: Study design and protocol
por: Russo, Vittoria, et al.
Publicado: (2021)

Adipocytes ESR1 Expression, Body Fat and Response to Testosterone Therapy in Hypogonadal Men Vary According to Estradiol Levels
por: Colleluori, Georgia, et al.
Publicado: (2018)

MON-382 Bone Quality and Strength in Obese Men with Type 2 Diabetes Mellitus Are Impaired and Negatively Influenced by Adiposity
por: Vigevano, Francesca, et al.
Publicado: (2020)

Fat Mass Follows a U-Shaped Distribution Based on Estradiol Levels in Postmenopausal Women
por: Colleluori, Georgia, et al.
Publicado: (2018)

OR27-01 Upregulated Prdm16 Impairs Adipogenesis And Promotes Myogenesis Via PAX7 And Osteogenesis In Testosterone-treated Hypogonadal Men
por: Bathina, Siresha, et al.
Publicado: (2023)

Baseline Testosterone Predicts Body Composition and Metabolic Response to Testosterone Therapy
por: Deepika, FNU, et al.
Publicado: (2022)

OR25-6 In Men on Testosterone Therapy, Baseline Testosterone Level of <264 ng/dL is Associated with Greater Improvement in Body Composition, While Level of ≥264 ng/dL Favors Improvement in Metabolic Profile
por: Aguirre, Lina, et al.
Publicado: (2022)

Hemoglobin A1c of 7% is the Threshold For Bone Impairment in Men With Type 2 Diabetes Mellitus
por: Joad, Sabaa Salim, et al.
Publicado: (2021)

Effect of Weight Loss, Exercise, or Both on Undercarboxylated Osteocalcin and Insulin Secretion in Frail, Obese Older Adults
por: Colleluori, Georgia, et al.
Publicado: (2017)

Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review
por: Russo, Vittoria, et al.
Publicado: (2021)

Hemoglobin A1c Threshold for Reduction in Bone Turnover in Men With Type 2 Diabetes Mellitus
por: Joad, Sabaa, et al.
Publicado: (2021)

ODP101 In Men with Type 2 Diabetes Mellitus, Poor Glycemic Control is Associated with Diminished Circulating Osteoblast Progenitors
por: Ballato, Elliot, et al.
Publicado: (2022)

Circulating osteogenic progenitors and osteoclast precursors are associated with long-term glycemic control, sex steroids, and visceral adipose tissue in men with type 2 diabetes mellitus
por: Ballato, Elliot, et al.
Publicado: (2022)

Weight Loss, Exercise, or Both and Cardiometabolic Risk Factors in Obese Older Adults: Results of a Randomized Controlled Trial
por: Bouchonville, Matthew, et al.
Publicado: (2013)

110. Bone Mineral Density Screening in Veterans Living with HIV
por: Khanjee, Naveed, et al.
Publicado: (2020)

Indices of sarcopenic obesity are important predictors of finite element analysis-derived bone strength in older adults with obesity
por: Gregori, Giulia, et al.
Publicado: (2023)

SUN-LB69 A Comparison Between Weight Loss Associated Bone Loss From Lifestyle Measures Versus Bariatric Surgery
por: La, Betty, et al.
Publicado: (2020)

Fat, Muscle, and Bone Interactions in Obesity and the Metabolic Syndrome
por: Armamento-Villareal, Reina, et al.
Publicado: (2014)

The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis
por: Bathina, Siresha, et al.
Publicado: (2023)

SUN-541 Effect of Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention in Frail, Older Male Veterans with Hypogonadism and Obesity: A Randomized Clinical Trial
por: Barnouin, Yoann, et al.
Publicado: (2020)

The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/Ethnic Backgrounds
por: Armamento-Villareal, Reina, et al.
Publicado: (2016)

Novel Adipokines and Their Role in Bone Metabolism: A Narrative Review
por: Deepika, Fnu, et al.
Publicado: (2023)

OR02-05 Effect of Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention on Cognitive Functions in Frail, Older Veterans with Hypogonadism and Obesity: A Randomized Clinical Trial
por: Gregori, Giulia, et al.
Publicado: (2020)

Sarcopenic Obesity Indices Are Major Determinants of Bone Strength in Older Adults With Obesity
por: Gregori, Giulia, et al.
Publicado: (2021)

Testosterone and Adipokines are Determinants of Physical Performance, Strength, and Aerobic Fitness in Frail, Obese, Older Adults
por: Aguirre, Lina E., et al.
Publicado: (2014)

Heightened levels of plasma growth differentiation factor 15 in men living with HIV
por: Agarwal, Neeti, et al.
Publicado: (2022)

Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men
por: Lee, John Alden, et al.
Publicado: (2018)

Aromatase Activity and Bone Loss in Men
por: Merlotti, Daniela, et al.
Publicado: (2011)

Depression in Nonclassical Hypogonadism in Young Men
por: Korenman, Stanley G, et al.
Publicado: (2018)

Hypogonadotropic hypogonadism in men with hereditary hemochromatosis
por: El Osta, Rabih, et al.
Publicado: (2017)

Induction of spermatogenesis in men with hypogonadotropic hypogonadism
por: Morris, Guy C., et al.
Publicado: (2021)

Aromatase inhibitors in men: effects and therapeutic options
por: de Ronde, Willem, et al.
Publicado: (2011)

Hypogonadism in Human Immunodeficiency Virus-Positive Men
por: Ashby, Jane, et al.
Publicado: (2014)

Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men
por: Lunenfeld, Bruno, et al.
Publicado: (2015)

Phenotypic spectrum and hormonal profile in hypogonadotropic hypogonadism
por: Păun, D, et al.
Publicado: (2014)

Associations between smoking, sex hormone levels and late-onset hypogonadism in men differ depending on age
por: Liu, Qian, et al.
Publicado: (2021)

Museo-Teatro Autónomo : instalación escénica de autonomías universitarias /
por: Villareal Alberto
Publicado: (2021)

All-Inside Partial Epiphyseal Anterior Cruciate Ligament Reconstruction Plus an Associated Modified Lemaire Procedure Sutured to the Femoral Button
por: Leyes-Vence, Manuel, et al.
Publicado: (2019)

Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels
por: Sigalos, John T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0muhs38fo7kc2gq41ea0ap3flr